Myovant Sciences and Pfizer announce US FDA acceptance of supplemental NDA for Myfembree
The US FDA set a target action date of 29th January, 2023 for this sNDA under the Prescription Drug User Fee Act (PDUFA)
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.